FDx Advisors’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,408
Closed -$512K 1983
2014
Q4
$512K Buy
2,408
+615
+34% +$122K 0.03% 545
2014
Q3
$319K Sell
1,793
-3
-0.2% -$498 0.02% 760
2014
Q2
$304K Sell
1,796
-241
-12% -$37.5K 0.02% 779
2014
Q1
$253K Sell
2,037
-1,378
-40% -$168K 0.02% 669
2013
Q4
$379K Buy
3,415
+489
+17% +$46.7K 0.04% 438
2013
Q3
$265K Sell
2,926
-263
-8% -$23.6K 0.03% 491
2013
Q2
$269K Buy
+3,189
New +$331K 0.04% 410

Other funds holding AGN

FDx Advisors's AGN Position: Q1 2015 in Review

FDx Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,408 shares — an estimated $512K sold.

FDx Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $512K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • FDx Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • FDx Advisors sold 2,408 Allergan Inc shares in Q1 2015, an estimated $512K.
  • FDx Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • FDx Advisors's Allergan Inc position peaked at $512K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on FDx Advisors's 13F filing for Q1 2015, filed 15 May 2015.